What is the catalog number for Amylmetacresol-d9?

The catalog number for Amylmetacresol-d9 is CS-T-103603.

What sizes are available for Amylmetacresol-d9?

Amylmetacresol-d9 is available in the following size(s): 1 Each.

Is Amylmetacresol-d9 in stock?

Amylmetacresol-d9 is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Amylmetacresol-d9?

The safety data sheet for Amylmetacresol-d9 is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-T-103603.

Amylmetacresol-d9

Amylmetacresol-d9 is listed under Stable Isotope Reagent and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Amylmetacresol. The product is supplied by Clearsynth under CAT No. CS-T-103603. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Amylmetacresol-d9 is the labelled analogue of Amylmetacresol (A636000), a compound used in the treatment of sore throat or Ã¢â¬Ëacute sore throat', pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.

CAS Number

2733539-33-6

Synonyms

Amylmetacresol-d9

Molecular Formula

C 12 H 9 D 9 O

Molecular Weight

187.33

Additionnal Information

Amylmetacresol-d9 is supplied with detailed characterization data compliant with regulatory guideline. Amylmetacresol-d9 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Amylmetacresol.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

Amylmetacresol-d9 is the labelled analogue of Amylmetacresol (A636000), a compound used in the treatment of sore throat or Ã¢â¬Ëacute sore throat', pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.